Publicacións en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (47)

2024

  1. Evaluation of the burden of migraine on the partner's lifestyle

    Neurologia, Vol. 39, Núm. 9, pp. 810-819

2023

  1. Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project

    Neurologia, Vol. 38, pp. S22-S30

  2. Study about the Manchester Triage System subtriage in patients that visited the Emergency Department due to headache

    Neurologia, Vol. 38, Núm. 4, pp. 270-277

2022

  1. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

  2. In episodic cluster headache, pain extent is not related to widespread pressure pain sensitivity, psychological outcomes, or clinical outcomes

    Physiotherapy Theory and Practice, Vol. 38, Núm. 9, pp. 1305-1310

  3. Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection

    Cephalalgia, Vol. 42, Núm. 14, pp. 1521-1531

2021

  1. Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients

    Expert Review of Neurotherapeutics, Vol. 21, Núm. 1, pp. 123-130

  2. Current clinical practice in disabling and chronic migraine in the primary care setting: results from the European My-LIFE anamnesis survey

    BMC Neurology, Vol. 21, Núm. 1

  3. Daily headache in chronic migraine is a predictive factor of response in patients who had completed three sessions of OnabotulinumtoxinA

    Toxins, Vol. 13, Núm. 6

  4. Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown

    Neurological Sciences, Vol. 42, Núm. 12, pp. 5087-5092

  5. Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine

    Pain medicine (Malden, Mass.), Vol. 22, Núm. 9, pp. 2079-2091

  6. Failure to monoclonal antibodies against CGRP or its receptor does not preclude lack of efficacy to other drugs from the same therapeutic class

    Neurologia

  7. Linear Headache: A Novel Entity or a Variant of Nummular Headache? Clinical Characteristics and Treatment Response in a Series of 16 Patients

    Pain medicine (Malden, Mass.), Vol. 22, Núm. 5, pp. 1158-1166

  8. Management of thunderclap headache in the emergency room: A retrospective cohort study

    Cephalalgia, Vol. 41, Núm. 6, pp. 711-720

  9. Multimodal fusion analysis of structural connectivity and gray matter morphology in migraine

    Human Brain Mapping, Vol. 42, Núm. 4, pp. 908-921

  10. Need of guidance in disabling and chronic migraine identification in the primary care setting, results from the european MyLife anamnesis survey

    BMC Family Practice, Vol. 22, Núm. 1

  11. Pain catastrophising in a population of patients with migraine

    Neurologia, Vol. 36, Núm. 1, pp. 24-28

  12. Patients and general practitioners assessment of the main outcomes employed in the acute and preventive treatment of migraine: a cross sectional study

    BMC Neurology, Vol. 21, Núm. 1

  13. Previous History of Migraine Is Associated With Fatigue, but Not Headache, as Long-Term Post-COVID Symptom After Severe Acute Respiratory SARS-CoV-2 Infection: A Case-Control Study

    Frontiers in Human Neuroscience, Vol. 15

  14. Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study

    Scientific Reports, Vol. 11, Núm. 1